Fundz

Vira Cyte, Inc. reported raising $30 Million in an initial SEC Form D filing, from an offering of $50 Million

PUBLIC · KLRSOct 02, 2018$30M of $50M raised

Amount Raised

$30 Million

$30 Million sold, per SEC Form D (first sale Oct 2, 2018)

Round Type

Venture

Berkeley HeightsBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

Kalaris Therapeutics raised $30 Million in a funding round, dated October 2, 2018. Kalaris Therapeutics is based in Berkeley Heights, New Jersey, United States.

How much did Kalaris Therapeutics raise?
Kalaris Therapeutics raised $30 Million in a funding round on October 2, 2018.
What does Kalaris Therapeutics do?
Kalaris Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases with major unmet medical needs.
Where is Kalaris Therapeutics based and how big is it?
Kalaris Therapeutics is based in Berkeley Heights, New Jersey, United States.
Who are the decision-makers at Kalaris Therapeutics?
Fundz holds 1 contact at Kalaris Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Kalaris Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Milestone Pharmaceuticals raised $80M on October 26, 2018.
  • VistaGen raised $4.8M on September 21, 2018.
  • Fulcrum Therapeutics raised $80M on September 5, 2018.
  • Zevra Therapeutics, Inc. raised $1.1M (Seed) on November 2, 2018.
  • Vivani Medical, Inc. raised $4M (Seed) on October 23, 2018.
  • Camp4 Therapeutics Corp raised $34M on September 25, 2018.

Who to call at Kalaris Therapeutics, and when

A new round usually means Kalaris Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kalaris Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kalaris Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kalaris Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kalaris Therapeutics

Location

Berkeley Heights, New Jersey, United States

About

Kalaris Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases with major unmet medical needs. Founded by renowned scientist Dr. Napoleone Ferrara, whose pioneering research led to the development of anti-VEGF therapy, the company is committed to advancing novel therapeutic approaches for patients with sight-threatening retinal conditions such as neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kalaris Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts13 people are listed at Kalaris Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kalaris Therapeutics's next move

See what Strategic adds

Kalaris Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.